NCT00242229View on ClinicalTrials.gov

Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Major Depressive Disorder
Interventions
DRUG

DVS-233 SR

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00242229 - Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter